Matrix to Pursue Strategic Alternatives Including Potential Divestiture of Docpharma
Matrix Laboratories Ltd has informed BSE that the Management of the company has been authorized to explore strategic alternatives for Docpharma, including a possible divestiture of the Docpharma business.
In this regard the Company has issued following press release
The Company, a subsidiary of Mylan Inc. announced that its Board of Directors has authorized its management to […]
